DOCSLIB.ORG

Journey Through the Thymus: Stromal Guides for T-Cell Development and Selection

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Journey Through the Thymus: Stromal Guides for T-Cell Development and Selection FOCUS ON EARLY LYMPHOCYTE DEVELROEPVMIEEWNST Journey through the thymus: stromal guides for T-cell development and selection Yousuke Takahama Abstract | Lympho–stromal interactions in multiple microenvironments within the thymus have a crucial role in the regulation of T-cell development and selection. Recent studies have implicated that chemokines that are produced by thymic stromal cells have a pivotal role in positioning developing T cells within the thymus. In this Review, I discuss the importance of stroma-derived chemokines in guiding the traffic of developing thymocytes, with an emphasis on the processes of cortex-to-medulla migration and T-cell-repertoire selection, including central tolerance. “…and yet men are so foolishly venturous as to set out to provide the appropriate microenvironments for lightly on pilgrimage, and to come without a guide.” promoting and regulating further thymocyte develop- John Bunyan ment13–16. Therefore, the lympho–stromal communica- tion is a bilateral coordination, or crosstalk, between The thymus is an organ that supports the differentia- architectural stromal cells and travelling thymocytes14. tion and selection of T cells1–3. The thymic development The travelling thymocytes have to create their own path of T cells consists of several processes that require the by letting their presence be known to the stromal cells dynamic relocation of developing lymphocytes into, and by changing the stromal environment for further within and out of the multiple environments of the thy- development. Despite this ability, however, most of mus (FIG. 1). These processes include: first, the entry of the thymocytes are unable to complete their journey lymphoid progenitor cells into the thymus; second, the through the thymus, so that they are seldom ‘happy generation of CD4+CD8+ double-positive (DP) thymo- tourists’ travelling through various thymic scenes. cytes at the outer cortex of the thymus; third, the positive Consequently, the crosstalk between thymocytes and and negative selection of DP thymocytes in the cortex; thymic stromal cells offers the view that developing fourth, the interaction of positively selected thymo cytes thymocytes resemble ‘path-making pilgrims’ who make with medullary thymic epithelial cells (mTECs) to their way through the thymus, struggling for their life complete thymocyte development and ensure central beyond the thymus. tolerance; and last, the export of mature T cells from the Among such crosstalk signals, chemokines that are thymus4–9 (FIG. 2). produced by thymic stromal cells in individual micro- For developing thymocytes to experience these key environments seem to have a pivotal role in guiding events at the right places and in the right order, the the direction of migrating thymocytes, and develop- developing thymocytes and thymic stromal cells have ing thymocytes seem to find their way by sequentially to communicate with each other both in close prox- expressing different chemokine receptors. Recent stud- imity and remotely. However, this lympho–stromal ies of mice that are deficient for certain chemokines or Division of Experimental communication does not readily fit a typical textbook chemokine receptors have shown the important role Immunology, Institute view of thymic education, in which the stromal ‘teacher’ of chemotactic guidance in controlling T-cell develop- for Genome Research, unilaterally instructs the lymphocyte ‘apprentices’ in the ment in the thymus (TABLE 1). This Review summarizes University of Tokushima, thymus ‘classroom’. In fact, thymocyte development our current understanding of the trafficking of devel- 3-18-15 Kuramoto, involves a stringent repertoire selection in which only oping thymocytes and the crosstalk in the thymus, Tokushima 770-8503, Japan. e-mail: takahama@genome. 1–3% of thymocytes succeed in survival and export and provides a discussion of the role of chemo tactic 10–12 tokushima-u.ac.jp from the thymus . In addition, thymic stromal cells signals in regulating thymocyte trafficking and doi:10.1038/nri1781 need to be closely coached by developing thymocytes development. NATURE REVIEWS | IMMUNOLOGY VOLUME 6 | FEBRUARY 2006 | 127 © 2006 Nature Publishing Group REVIEWS Thymic primordium Entry of T-progenitor cells into the thymus In the postnatal thymus, lymphoid progenitor cells that The primordium refers to an The seeding of the thymus with lymphoid progeni- have just entered the thymic parenchyma are found mainly organ or tissue in its earliest tor cells (BOX 1) occurs as early as embryonic day 11.5 in the area close to the cortico–medullary junction, where recognizable stage of (E11.5) in mice and the eighth week of gestation in the vasculature is well developed, indicating that the development. The primordium 17,18 of the thymus is generated at humans , and is mediated by at least two different lymphoid progenitor cells enter the postnatal thymus by the ventral aspect of the third pathways: the vasculature-independent pathway, which transmigrating from the blood to the thymic parenchyma, pharyngeal pouch as early as probably occurs during the early stage of embryonic mainly through the area around the cortico–medullary embryonic day 10.5 in mice. development before vascularization of the thymus, and junction23 (FIG. 2a). Whereas the role of chemokines in the vasculature-dependent pathway, which probably postnatal thymus seeding is unclear, it has been reported Thymic parenchyma The parenchyma refers to the occurs in the late stage of embryogenesis and post natally that thymus seeding of the adult thymus is regulated by functional part of an organ. after vascularization. It is thought that vasculature- the adhesive interaction between platelet (P)-selectin The parenchyma of the thymus independent colonization of the fetal thymus is regulated glycoprotein ligand 1 (PSGL1), which is expressed by cir- is surrounded by the capsule, by the chemotactic attraction of lymphoid progenitor culating lymphoid progenitor cells, and P-selectin, which the trabeculae and the thymic primordium (FIG. 3a) 24 perivascular spaces. cells to the . The partial but is expressed by the thymic endothelium . Interestingly, significant roles of two chemokines, CC-chemokine lig- the entry of lymphoid progenitor cells into the thymus and 21 (CCL21) and CCL25, in this early stage of fetal is not a continuous event but an intermittent and gated thymus colonization have been reported19–21. CCL21 event that occurs in waves during embryogenesis and in and CCL25 are expressed by the fetal thymus primor- adulthood25–27. During embryogenesis, distinct waves of dium, along with several other chemokines19,20. In a thymus-colonized cells give rise to distinct progenies naturally occurring mutant mouse strain plt/plt, which of γδ T cells with different usages of T-cell receptor (TCR)- is deficient for CCL21, or in mice that are deficient for Vγ and Vδ chains, indicating that T-lymphoid progenitor CC-chemokine receptor 7 (CCR7), which is the recep- cells that colonize the fetal thymus differ in developmental tor for CCL21, the number of thymocytes was partially potential from T-lymphoid progenitor cells that enter the but significantly lower than that in normal mice until postnatal thymus27–31. In the adult thymus, the receptivity E14.5 (REF. 20). Mice deficient for CCR9, the receptor to chimerism of total thymocytes (largely of the αβ T-cell for CCL25, showed a three-fold decrease in total thymo- lineage) varies cyclically with a periodicity of 3–5 weeks cyte cellularity until E17.5 (REF. 21). These results indicate in non-irradiated mice, as shown by quantitative intra- that CCL21 and CCL25 are partially involved in fetal venous bone-marrow adoptive-transfer experiments and thymus colonization. Whether the combination of the timed separation of parabiotic adult mice25. CCL21 and CCL25 is sufficient for fetal thymus coloni- zation or whether other chemokines also have a role in Cortex formation and outward traffic this process is unclear. It has also been shown that CXC- Following entry into the thymus, lymphoid progeni- chemokine ligand 12 (CXCL12) and its receptor tor cells begin their development into T cells through CXC-chemokine receptor 4 (CXCR4) are not involved the developmental pathway that is commonly identi- in early fetal thymus colonization22. fied by the expression profiles of CD25 and CD44, a Human b Mouse Cortico– Subcapsular medullary Capsule Trabeculae Hassall’s corpuscles zone Cortex junction Trabeculae Subcapsular Cortex Cortico–medullary Medulla Capsule Medulla zone junction Figure 1 | The thymus architecture. a | The human thymus section from a newborn child was stained with haematoxylin and eosin. b | The thymus section from an adult C57BL/6 mouse was stained for CD4 (green), CD8 (blue), and medullary thymic epithelial cells defined using Ulex europaeus agglutinin 1 (red). Cells in cyan indicate the co-expression of CD4 and CD8, therefore being CD4+CD8+ double-positive cells. 128 | FEBRUARY 2006 | VOLUME 6 www.nature.com/reviews/immunol © 2006 Nature Publishing Group FOCUS ON EARLY LYMPHOCYTE DEVELROEPVMIEEWNST Along this developmental pathway, immature DN thymocytes promote the differentiation of thymic stromal cells and trigger the formation of the cortical- Trabeculae epithelial environment in the thymus15,16,38,39. In mice cTEC Fibroblast that are deficient for thymocyte development beyond the DN1 stage, such as a mouse strain carrying a trans- Developing thymocyte gene encoding human CD3ε, TECs are arrested at the b PSGL1 DC immature stage,
Load more

Recommended publications
  • Horse Gamma Globulin Stabilized in 0.3 Molar Glycine to a Ph of Approximately 6.8
    LPD Reference: ATG-SIN-0414/1 Date of Last Revision: 08 September 2014 Country: Singapore Reference document: CDS Version 3.0, effective date: 17-Mar-2014 Reason for change: LPD update in accordance with CDS 3.0 ; 2014-09-08 IR: 1. Remove entire proposed subsection <Renal Transplant Prophylaxis> under ‘Pharmacodynamic Properties - Clinical Studies’ & 2. Relocate paragraph “Clinical trials […] standard supportive care alone” from <Therapeutic Indications> to < Pharmacodynamic Properties - Clinical Studies>, subsection <Aplastic Anemia>. Atgam® lymphocyte immune globulin, anti-thymocyte globulin [equine] sterile solution For Intravenous Use only DESCRIPTION ATGAM Sterile Solution contains lymphocyte immune globulin, anti-thymocyte globulin [equine]. It is the purified, concentrated, and sterile gamma globulin, primarily monomeric IgG, from hyperimmune serum of horses immunized with human thymus lymphocytes. Anti-thymocyte globulin (equine) is a transparent to slightly opalescent aqueous protein solution. It may appear colorless to faintly pink or brown and is nearly odorless. It may develop a slight granular or flaky deposit during storage. (For information about in-line filters, see Infusion Instructions in the POSOLOGY AND METHOD OF ADMINISTRATION.) Before release for clinical use, each lot of anti-thymocyte globulin (equine) is tested to assure its ability to inhibit rosette formation between human peripheral lymphocytes and sheep red blood cells in vitro. In each lot, antibody activity against human red blood cells and platelets is also measured and determined to be within acceptable limits. Only lots that test negative for antihuman serum protein antibody, antiglomerular basement membrane antibody and pyrogens are released. Each milliliter of anti-thymocyte globulin (equine) contains 50 mg of horse gamma globulin stabilized in 0.3 molar glycine to a pH of approximately 6.8.
    [Show full text]
  • Our Immune System (Children's Book)
    OurOur ImmuneImmune SystemSystem A story for children with primary immunodeficiency diseases Written by IMMUNE DEFICIENCY Sara LeBien FOUNDATION A note from the author The purpose of this book is to help young children who are immune deficient to better understand their immune system. What is a “B-cell,” a “T-cell,” an “immunoglobulin” or “IgG”? They hear doctors use these words, but what do they mean? With cheerful illustrations, Our Immune System explains how a normal immune system works and what treatments may be necessary when the system is deficient. In this second edition, a description of a new treatment has been included. I hope this book will enable these children and their families to explore together the immune system, and that it will help alleviate any confusion or fears they may have. Sara LeBien This book contains general medical information which cannot be applied safely to any individual case. Medical knowledge and practice can change rapidly. Therefore, this book should not be used as a substitute for professional medical advice. SECOND EDITION COPYRIGHT 1990, 2007 IMMUNE DEFICIENCY FOUNDATION Copyright 2007 by Immune Deficiency Foundation, USA. Readers may redistribute this article to other individuals for non-commercial use, provided that the text, html codes, and this notice remain intact and unaltered in any way. Our Immune System may not be resold, reprinted or redistributed for compensation of any kind without prior written permission from Immune Deficiency Foundation. If you have any questions about permission, please contact: Immune Deficiency Foundation, 40 West Chesapeake Avenue, Suite 308, Towson, MD 21204, USA; or by telephone at 1-800-296-4433.
    [Show full text]
  • Visualizing B Cell Development: Creating an Immunology Video Game
    VISUALIZING B CELL DEVELOPMENT: CREATING AN IMMUNOLOGY VIDEO GAME By Emily Lunhui Ling A thesis submitted to Johns Hopkins University in conformity with the requirements for the degree of Master of Arts Baltimore, Maryland March, 2016 © 2016 Emily L. Ling All Rights Reserved ABSTRACT e foundational immunology concepts of lymphocyte development are important for beginning science students to comprehend. Video games oer the potential for a novel approach to teaching this complex subject matter by more eectively engaging students in this material. However, currently available educational video games intended to teach immunology have distinct limitations such as a lack of explicit demonstrations of the stages of lymphocyte development and clonal selection. is project identies the content focus and gameplay mechanics of currently available immunology video games. Using this as a basis, a novel approach for developing an immunology video game was outlined with the primary goal of improving integration of educational content. A proof of concept was developed for the B lymphocyte development portion of the game content and a partial prototype was developed in Unity 5 3D. e important contribution of this thesis was the development of a new approach to designing a more eective educational video game specically for immunology. Outcomes of this research will serve to inform future biomedical communicators on how to develop content for active learning games in immunology and provide a guide for designing full length educational video games featuring novel gameplay mechanics such as those identied through this project. Emily L. Ling ii CHAIRPERSONS OF THE SUPERVISORY COMMITTEE esis Preceptor Mark J. Soloski, Ph.D., Professor of Medicine Departments of Medicine, Pathology, Molecular Biology and Genetics, and Molecular Microbiology and Immunology Director, Immunology Training Program e Johns Hopkins University School of Medicine Departmental Advisor David A.
    [Show full text]
  • Review Article Mesenchymal Stromal Cells Affect Disease Outcomes Via Macrophage Polarization
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation Stem Cells International Volume 2015, Article ID 989473, 11 pages http://dx.doi.org/10.1155/2015/989473 Review Article Mesenchymal Stromal Cells Affect Disease Outcomes via Macrophage Polarization Guoping Zheng,1 Menghua Ge,1 Guanguan Qiu,1 Qiang Shu,2 and Jianguo Xu1,3 1 Shaoxing Second Hospital, Shaoxing, Zhejiang 312000, China 2The Children’s Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, China 3The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China Correspondence should be addressed to Jianguo Xu; [email protected] Received 18 May 2015; Accepted 30 June 2015 Academic Editor: Armand Keating Copyright © 2015 Guoping Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Mesenchymal stromal cells (MSCs) are multipotent and self-renewable cells that reside in almost all postnatal tissues. In recent years, many studies have reported the effect of MSCs on the innate and adaptive immune systems. MSCs regulate the proliferation, activation, and effector function of T lymphocytes, professional antigen presenting cells (dendritic cells, macrophages, and B lymphocytes), and NK cells via direct cell-to-cell contact or production of soluble factors including indoleamine 2,3-dioxygenase, prostaglandin E2, tumor necrosis factor- stimulated gene/protein 6, nitric oxide, and IL-10. MSCs are also able to reprogram macrophages from a proinflammatory M1 phenotype toward an anti-inflammatory M2 phenotype capable of regulating immune response.
    [Show full text]
  • FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Archivio della ricerca - Università degli studi di Napoli Federico II J Clin Immunol DOI 10.1007/s10875-017-0445-z CME REVIEW FOXN1 Deficiency: from the Discovery to Novel Therapeutic Approaches Vera Gallo1 & Emilia Cirillo1 & Giuliana Giardino1 & Claudio Pignata1 Received: 29 June 2017 /Accepted: 11 September 2017 # Springer Science+Business Media, LLC 2017 Abstract Since the discovery of FOXN1 deficiency, the hu- cellular and humoral immunity. To date, more than 20 genetic man counterpart of the nude mouse, a growing body of evi- alterations have been identified as responsible for the disease dence investigating the role of FOXN1 in thymus and skin, [1]. Among these, the FOXN1 gene mutation, causative of the has been published. FOXN1 has emerged as fundamental for nude SCID phenotype, is the unique condition in which the thymus development, function, and homeostasis, representing immunological defect is related to an alteration of the thymic the master regulator of thymic epithelial and T cell develop- epithelial stroma and not to an intrinsic defect of the hemato- ment. In the skin, it also plays a pivotal role in keratinocytes poietic cell. The nude SCID phenotype has been identified in and hair follicle cell differentiation, although the underlying human for the first time in 1996 in two female patients who molecular mechanisms still remain to be fully elucidated. The presented with thymus aplasia and ectodermal abnormalities nude severe combined immunodeficiency phenotype is in- [2], approximately 30 years later than the initial description of deed characterized by the clinical hallmarks of athymia with the murine counterpart.
    [Show full text]
  • Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling1
    2912 Vol. 8, 2912–2923, September 2002 Clinical Cancer Research Reactive Stroma in Human Prostate Cancer: Induction of Myofibroblast Phenotype and Extracellular Matrix Remodeling1 Jennifer A. Tuxhorn, Gustavo E. Ayala, Conclusions: The stromal microenvironment in human Megan J. Smith, Vincent C. Smith, prostate cancer is altered compared with normal stroma and Truong D. Dang, and David R. Rowley2 exhibits features of a wound repair stroma. Reactive stroma is composed of myofibroblasts and fibroblasts stimulated to Departments of Molecular and Cellular Biology [J. A. T., T. D. D., express extracellular matrix components. Reactive stroma D. R. R.] and Pathology [G. E. A., M. J. S., V. C. S.] Baylor College of Medicine, Houston, Texas 77030 appears to be initiated during PIN and evolve with cancer progression to effectively displace the normal fibromuscular stroma. These studies and others suggest that TGF-␤1isa ABSTRACT candidate regulator of reactive stroma during prostate can- Purpose: Generation of a reactive stroma environment cer progression. occurs in many human cancers and is likely to promote tumorigenesis. However, reactive stroma in human prostate INTRODUCTION cancer has not been defined. We examined stromal cell Activation of the host stromal microenvironment is pre- phenotype and expression of extracellular matrix compo- dicted to be a critical step in adenocarcinoma growth and nents in an effort to define the reactive stroma environ- progression (1–5). Several human cancers have been shown to ment and to determine its ontogeny during prostate cancer induce a stromal reaction or desmoplasia as a component of progression. carcinoma progression. However, the specific mechanisms of Experimental Design: Normal prostate, prostatic intra- stromal cell activation are not known, and the extent to which epithelial neoplasia (PIN), and prostate cancer were exam- stroma regulates the biology of tumorigenesis is not fully un- ined by immunohistochemistry.
    [Show full text]
  • 1-Phosphate-Lyase-Deficient Mice Development in Sphingosine
    Discontinued Postnatal Thymocyte Development in Sphingosine 1-Phosphate-Lyase-Deficient Mice This information is current as Claudia Weber, Andreas Krueger, Anika Münk, Constantin of October 1, 2021. Bode, Paul P. Van Veldhoven and Markus H. Gräler J Immunol 2009; 183:4292-4301; Prepublished online 11 September 2009; doi: 10.4049/jimmunol.0901724 http://www.jimmunol.org/content/183/7/4292 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2009/09/10/jimmunol.090172 Material 4.DC1 http://www.jimmunol.org/ References This article cites 48 articles, 20 of which you can access for free at: http://www.jimmunol.org/content/183/7/4292.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Discontinued Postnatal Thymocyte Development in Sphingosine 1-Phosphate-Lyase-Deficient Mice1,2 Claudia Weber,3* Andreas Krueger,3* Anika Mu¨nk,* Constantin Bode,* Paul P.
    [Show full text]
  • Type 3 Innate Lymphoid Cells a Stromal Cell Niche for Human and Mouse
    A Stromal Cell Niche for Human and Mouse Type 3 Innate Lymphoid Cells Kerim Hoorweg, Priyanka Narang, Zhi Li, Anne Thuery, Natalie Papazian, David R. Withers, Mark C. Coles and Tom This information is current as Cupedo of September 28, 2021. J Immunol 2015; 195:4257-4263; Prepublished online 16 September 2015; doi: 10.4049/jimmunol.1402584 http://www.jimmunol.org/content/195/9/4257 Downloaded from References This article cites 42 articles, 9 of which you can access for free at: http://www.jimmunol.org/content/195/9/4257.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 28, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology A Stromal Cell Niche for Human and Mouse Type 3 Innate Lymphoid Cells Kerim Hoorweg,*,1 Priyanka Narang,†,1 Zhi Li,† Anne Thuery,† Natalie Papazian,* David R.
    [Show full text]
  • Tumor Microenvironment Consortium
    Tumor Microenvironment Network (TMEN) Dinah Singer, Ph.D. Director Suresh Mohla, Ph.D. TMEN Program Director Division of Cancer Biology TMEN 2006-2011: Goals – Generate a comprehensive understanding of the composition of the normal stroma and the role of the stroma in tumor initiation, progression and metastasis – Develop resources and infrastructure critical to the broader research community to advance understanding of the tumor microenvironment (TME) TMEN 2006-2011: Current Program •Nine interdisciplinary groups characterizing the TME in major cancer sites, emphasizing human samples •Identifying and translating promising leads •Collaboratively addressing the complexity of TME by assessing: • The co-evolution of tumor-associated stromal cell types and the tumor •Stromal cell interactions with each other and with tumor cells •Generating novel reagents, models and technologies for the research community TMEN 2006-2011: Areas of Emphasis Microenvironment Initiation Progression Metastasis – Tumor initiating cells – Tumor heterogeneity – Stromal cell types and cellular processes – Complex signaling pathways – Genes and genetics TMEN 2006-2011: Scientific Accomplishments Tumor Initiating Cells: • Combined invasive gene signatures in tumor initiating cells and stromal wound repair response genes robustly predict metastasis-free and overall survival in breast, medulloblastoma, lung and prostate cancer patients • New therapeutic approaches to circumvent the chemo- and radio-resistance of tumor initiating cells Stromal Cells: • Delineation of mechanisms
    [Show full text]
  • Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates
    Research Article Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates David Gius,1 Margo C. Funk,2 Eric Y. Chuang,1 Sheng Feng,3 Phyllis C. Huettner,4 Loan Nguyen,2 C. Matthew Bradbury,1 Mark Mishra,1 Shuping Gao,1 Barbara M. Buttin,2 David E. Cohn,2 Matthew A. Powell,2 Neil S. Horowitz,2 Bradford P. Whitcomb,2 and JanetS. Rader 2 1Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland and 2Division of Gynecologic Oncology, Department of Obstetrics and Gynecology; 3Division of Biostatistics; and 4Lauren V. Ackerman Laboratory of Surgical Pathology, Washington University School of Medicine, St. Louis, Missouri Abstract (CIN 1–3) and finally to squamous cell carcinoma antigen (SCCA) This study is the first comprehensive, integrated approach to have been well characterized. Histologically, CIN 1 consists of examine grade-specific changes in gene expression along the immature basal-type cells involving the lower third of the entire neoplastic spectrum of cervical intraepithelial neoplasia epithelium. In CIN 2, these immature basal-type cells involve more (CIN) in the process of cervical carcinogenesis. This was than the lower third, whereas CIN 3 involves the full thickness of the accomplished by identifying gene expression signatures of epithelium. In addition, higher CIN grades exhibit nuclear crowding, disease progression using cDNA microarrays to analyze RNA pleomorphism, loss of cell polarity, and increased mitotic activity from laser-captured microdissected epithelium and underlying (1). These transitions seemto be well conserved and, as such, stroma from normal cervix, graded CINs, cancer, and patient- provide an intriguing systemto use genomicsto identify the early matched normal cervical tissues.
    [Show full text]
  • Understanding the Immune System: How It Works
    Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute Understanding the Immune System How It Works U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Allergy and Infectious Diseases National Cancer Institute NIH Publication No. 03-5423 September 2003 www.niaid.nih.gov www.nci.nih.gov Contents 1 Introduction 2 Self and Nonself 3 The Structure of the Immune System 7 Immune Cells and Their Products 19 Mounting an Immune Response 24 Immunity: Natural and Acquired 28 Disorders of the Immune System 34 Immunology and Transplants 36 Immunity and Cancer 39 The Immune System and the Nervous System 40 Frontiers in Immunology 45 Summary 47 Glossary Introduction he immune system is a network of Tcells, tissues*, and organs that work together to defend the body against attacks by “foreign” invaders. These are primarily microbes (germs)—tiny, infection-causing Bacteria: organisms such as bacteria, viruses, streptococci parasites, and fungi. Because the human body provides an ideal environment for many microbes, they try to break in. It is the immune system’s job to keep them out or, failing that, to seek out and destroy them. Virus: When the immune system hits the wrong herpes virus target or is crippled, however, it can unleash a torrent of diseases, including allergy, arthritis, or AIDS. The immune system is amazingly complex. It can recognize and remember millions of Parasite: different enemies, and it can produce schistosome secretions and cells to match up with and wipe out each one of them.
    [Show full text]
  • A Novel BCMA/CD3 Bispecific T-Cell Engager for the Treatment
    OPEN Leukemia (2017) 31, 1743–1751 www.nature.com/leu ORIGINAL ARTICLE A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo S Hipp1, Y-T Tai2,3, D Blanset4, P Deegen5, J Wahl5, O Thomas5, B Rattel5, PJ Adam1, KC Anderson2,3 and M Friedrich5 B-cell maturation antigen (BCMA) is a highly plasma cell-selective protein that is expressed on malignant plasma cells of multiple myeloma (MM) patients and therefore is an ideal target for T-cell redirecting therapies. We developed a bispecific T-cell engager (BiTE) targeting BCMA and CD3ε (BI 836909) and studied its therapeutic impacts on MM. BI 836909 induced selective lysis of BCMA- positive MM cells, activation of T cells, release of cytokines and T-cell proliferation; whereas BCMA-negative cells were not affected. Activity of BI 836909 was not influenced by the presence of bone marrow stromal cells, soluble BCMA or a proliferation-inducing ligand (APRIL). In ex vivo assays, BI 836909 induced potent autologous MM cell lysis in both, newly diagnosed and relapsed/ refractory patient samples. In mouse xenograft studies, BI 836909 induced tumor cell depletion in a subcutaneous NCI-H929 xenograft model and prolonged survival in an orthotopic L-363 xenograft model. In a cynomolgus monkey study, administration of BI 836909 led to depletion of BCMA-positive plasma cells in the bone marrow. Taken together, these results show that BI 836909 is a highly potent and efficacious approach to selectively deplete BCMA-positive MM cells and represents a novel immunotherapeutic for the treatment of MM.
    [Show full text]